---
title: "Ayr Wellness Inc. (AYRWF.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AYRWF.US.md"
symbol: "AYRWF.US"
name: "Ayr Wellness Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-20T11:26:42.538Z"
locales:
  - [en](https://longbridge.com/en/quote/AYRWF.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AYRWF.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AYRWF.US.md)
---

# Ayr Wellness Inc. (AYRWF.US)

## Company Overview

Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.ayrwellness.com](https://www.ayrwellness.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: D (0.75)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 163 / 189 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.39% |  |
| Net Profit YoY | -68.77% |  |
| P/B Ratio | 0.01 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1652346.54 |  |
| Revenue | 452899000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -65.72% | E |
| Profit Margin | -68.53% | E |
| Gross Margin | 30.58% | C |
| Revenue YoY | -2.39% | D |
| Net Profit YoY | -68.77% | E |
| Total Assets YoY | -14.74% | E |
| Net Assets YoY | -49.03% | E |
| Cash Flow Margin | -3.76% | D |
| OCF YoY | -2.39% | D |
| Turnover | 0.33 | D |
| Gearing Ratio | 75.37% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Ayr Wellness Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-2.39%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-68.77%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.01",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1652346.54",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "452899000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-65.72%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-68.53%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "30.58%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-2.39%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-68.77%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-14.74%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-49.03%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-3.76%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-2.39%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.33",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "75.37%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.01 | 59/189 | - | - | - |
| PB | 0.01 | 1/189 | 0.02 | 0.01 | 0.01 |
| PS (TTM) | 0.00 | 1/189 | 0.01 | 0.01 | 0.00 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2025-08-01T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.01 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/AYRWF.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/AYRWF.US/norm.md)
- [Related News](https://longbridge.com/en/quote/AYRWF.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/AYRWF.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**